2017-2021 US Molecular Diagnostic Testing Market: Supplier Shares and Market Segment Sales Forecasts

January 2017 | 42 pages | ID: U550E18F545EN
Venture Planning Group

Abstracts

This report provides an overview of the US molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Contents

Business Environment
  1. HEALTH CARE EXPENDITURES
  2. COST CONSCIOUSNESS
  3. REIMBURSEMENT
  4. INDUSTRY CONSOLIDATION
  5. MANAGED CARE
    a. PPO
    b. HMO
  6. HOSPITALS
  7. ADMISSIONS
  8. LENGTH OF STAY
  9. INDUSTRY DIVERSIFICATION
  10. PHYSICIAN DEMOGRAPHICS
  11. POPULATION AGING
    a. Chronic Illness
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  12. LABORATORY REGULATIONS
  13. FDA REFORM
Market Structure
  1. HOSPITALS
  2. COMMERCIAL/PRIVATE LABORATORIES
  3. BLOOD BANKS
Market Size, Growth and Major Suppliers’ Market Shares

List Of Tables

LIST OF TABLES

Molecular Diagnostics Test Volume Forecasts by Application
Molecular Diagnostic Sales Forecasts by Application
Market Share of Major Supplier of Molecular Diagnostic Tests
Market Shares of Major Supplier of HIV/Hepatitis Blood Screening Assays
Market Share of Major Supplier of West Nile Virus Blood Screening Assays